miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner - Wikidata - wikimedia - TriplyDB

miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner

miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner

http://www.wikidata.org/entity/Q33901567

about

MicroRNA aberrations: An emerging field for gallbladder cancer management Non-coding RNAs in lung cancer MicroRNA-34a: a potential therapeutic target in human cancer Regulatory mechanisms of microRNAs in lung cancer stem cells Therapeutic use of microRNAs in lung cancer Involvement of microRNA lethal-7a in the regulation of embryo implantation in mice MicroRNAs in Muscle: Characterizing the Powerlifter Phenotype.A novel small-molecule compound diaporine A inhibits non-small cell lung cancer growth by regulating miR-99a/mTOR signaling.Genetic networks lead and follow tumor development: microRNA regulation of cell cycle and apoptosis in the p53 pathways.Prenatal exposure to TCDD triggers significant modulation of microRNA expression profile in the thymus that affects consequent gene expression Aberrant Expression of MicroRNA-15a and MicroRNA-16 Synergistically Associates with Tumor Progression and Prognosis in Patients with Colorectal Cancer Large-scale screening identifies a novel microRNA, miR-15a-3p, which induces apoptosis in human cancer cell lines.Constructing and characterizing a bioactive small molecule and microRNA association network for Alzheimer's disease.The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma.MicroRNA as tools and therapeutics in lung cancer Tanshinones suppress AURKA through up-regulation of miR-32 expression in non-small cell lung cancer.MicroRNA dysregulation in the tumor microenvironment influences the phenotype of pancreatic cancer.MiR-29a and MiR-140 Protect Chondrocytes against the Anti-Proliferation and Cell Matrix Signaling Changes by IL-1β MicroRNA-34a Plays a Key Role in Cardiac Repair and Regeneration Following Myocardial Infarction.Chicken gga-miR-103-3p Targets CCNE1 and TFDP2 and Inhibits MDCC-MSB1 Cell Migration.Involvement of miR-15a in G0/G1 Phase Cell Cycle Arrest Induced by Porcine Circovirus Type 2 Replication.The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas.Therapeutic evaluation of microRNAs by molecular imaging Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancer Reduced miR-3127-5p expression promotes NSCLC proliferation/invasion and contributes to dasatinib sensitivity via the c-Abl/Ras/ERK pathway.MicroRNAs and lung cancers: from pathogenesis to clinical implications MicroRNAs in the p53 network: micromanagement of tumour suppression.The p53 miRNA interactome and its potential role in the cancer clinic.MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications.Non-small-cell lung cancer and miRNAs: novel biomarkers and promising tools for treatment.The expression of microRNA-34a is inversely correlated with c-MET and CDK6 and has a prognostic significance in lung adenocarcinoma patients.Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles.Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging.Is miR-34a a Well-equipped Swordsman to Conquer Temple of Molecular Oncology?The mechanisms for lung cancer risk of PM2.5 : Induction of epithelial-mesenchymal transition and cancer stem cell properties in human non-small cell lung cancer cells.Targeting noncoding RNAs in disease.miR-34 activity is modulated through 5'-end phosphorylation in response to DNA damage.Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.MicroRNA-138 negatively regulates non-small cell lung cancer cells through the interaction with cyclin D3.

P2860

Q26768416-C681AEBE-1FC0-4B06-BA4C-F54810DED4E4 Q26866521-2F6E6C92-BCD7-4415-A9BE-6AC79C902765 Q27003249-D9DDC93D-95CA-4B78-8B20-F1EB6028F78A Q28072716-E1AC7AF8-E422-4F0D-9C4F-02F8680391AB Q28395179-72E2C45B-51A9-461C-BA90-05E0305C1674 Q28729856-5B67502C-6F9B-4D7D-B27F-3A93BA7128AA Q33770477-4272A3FD-8447-4A24-8E39-D366A5A6AB07 Q34036145-7BC897BD-CA67-40B4-AE58-499D7E42690B Q34268565-F138776E-CF54-4254-9DDE-14AF6AA80B7E Q34425208-F37651C1-D792-4951-B2D8-D00A8C786AB3 Q34540200-0CA8D44A-BD6B-4F11-93CC-906A722DD1ED Q34564608-55911BC5-2313-487C-9FEC-055253594C7E Q35071638-912794B7-CBCC-469B-8A47-751944CC8315 Q35111253-19B83801-3E08-485F-9926-1C15FFFEB498 Q35127831-20034999-372B-4E1D-8355-920E01A0AFA1 Q35738706-3C6FD293-7DB1-4D1C-B137-F1E9FDD69D61 Q36299594-A5D72DD3-0BD1-4886-9355-1B87E9FF0230 Q36382688-CB4706D5-A238-425B-B78D-3B6E21B353B9 Q36591281-D12AF91D-4D90-4BA8-8887-CDE753DBD6A2 Q36626642-B3498870-B3FD-4658-954B-820B02F4C2B6 Q36867890-C50795E1-B058-4C7F-A83F-1A1AC3F3A0A2 Q37005696-74A0656D-941C-4343-A86D-4B55D87BABA7 Q37041036-C61153AF-9905-42D1-A5B8-FCFECA8B6D36 Q37434627-35AF3021-AA42-4A59-9610-9BFB7F98A915 Q37536891-7696472F-5A0B-4A63-B601-62464E70D189 Q37734888-C02B9824-1945-47AC-90D4-81F1609C31C9 Q38005062-C803A475-E9D3-4C1B-902C-1EBC5DC467CE Q38035144-204C6D27-D4AE-44FD-84C3-CA6AD3F44412 Q38124951-B58A4297-A433-4DFD-B9D7-F582E6793BFB Q38174308-87B96627-82B1-47DE-9118-BD396C6695ED Q38373911-DABFCB1F-6DC4-4B47-A9F6-039959B527BF Q38385755-44DB928C-B52D-4CF6-9F48-ADD0CE3CC8D1 Q38430180-7E27D682-1EC2-46A0-B8A0-FD2F6DDBD26E Q38449526-5353F7D7-12B9-4D9E-A81C-1402B01C6E75 Q38561614-7F96E7FB-E563-477F-A057-220A6D927CD2 Q38605872-A204E920-A97E-4408-8FE2-4D96B1895451 Q38752040-71C2F25D-D94F-4D02-8694-DDE7BF3DAB0C Q38784668-32B9B7A1-78C7-4D98-939D-C4D8E5194B39 Q38826546-D90A8DAC-5085-48B7-A769-0DBDF0FACC6D Q38850375-6379D51A-AF07-449C-A131-E940F5377157

P2860

miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner

http://www.wikidata.org/entity/Q33901567

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

miR-34a and miR-15a/16 are co- ...... gistic and Rb-dependent manner

@ast

miR-34a and miR-15a/16 are co- ...... gistic and Rb-dependent manner

@en

type

label

miR-34a and miR-15a/16 are co- ...... gistic and Rb-dependent manner

@ast

miR-34a and miR-15a/16 are co- ...... gistic and Rb-dependent manner

@en

prefLabel

miR-34a and miR-15a/16 are co- ...... gistic and Rb-dependent manner

@ast

miR-34a and miR-15a/16 are co- ...... gistic and Rb-dependent manner

@en

P1433

Q33901567-C4B02EAF-67B0-4AD7-98D2-85D4AFDBC68D

P1476

Q33901567-3F4C06D1-7446-4125-92E6-6E7CB7A27E6D

P2093

Q33901567-50ECCA24-9BC6-4D0A-8E1C-636A2E0D49EA

Q33901567-A5BE5A11-1938-410A-8E7E-5BF1F23B5575

P2860

Q33901567-04633A46-BC24-4B02-A3BE-6EBF820183D2

Q33901567-0F307FA8-FB45-47F3-9C9F-71405A582352

Q33901567-1FD80095-95F2-47A3-BA4C-1D061B954F65

Q33901567-26691F75-39DB-4E5A-A160-F7D8FF8D5D13

Q33901567-27E75DEA-7F6B-4D2B-A508-65804BFF2091

Q33901567-2944551F-DB52-4A44-BA4D-BBD1419B3955

Q33901567-2D33E678-2696-4DF2-B16E-48C86A354749

Q33901567-34EA8EC4-3357-4A7E-92ED-09C8A14002DA

Q33901567-3ACD1B1E-D91A-4BE6-9772-E029AAADE3DE

Q33901567-3E72202B-ECD9-4EA4-8A80-0D3D876B024F

P2888

Q33901567-CBD13874-361E-486A-8F98-9F6C8B240272

P304

Q33901567-0130C563-55AC-48F6-AA14-A5D743569BD4

P31

Q33901567-ABA2B7C0-11FA-4FE1-9A94-1F1E922949A6

P356

Q33901567-A19A64C6-F529-47FF-9EC0-0D887BEB3D22

P478

Q33901567-7EBB3506-1377-42DA-8A6E-36D4228AC737

P577

Q33901567-911E19C1-A928-48AA-ACDA-107BECE8E638

P5875

Q33901567-97F8D967-4931-422E-8055-76C9F345A3E7

P6179

Q33901567-E7F01F1A-B623-4FB0-A6D1-D7AA4021155A

P698

Q33901567-4EA4EB45-80B7-4D9B-9AAF-BBEAB022A946

P932

Q33901567-2DDDAEDC-90B2-494E-B7E7-08CDAE9900D9

P356

1476-4598-10-55

P1433

Molecular Cancer

P1476

miR-34a and miR-15a/16 are co- ...... gistic and Rb-dependent manner

@en

P2093

Erik Vassella

http://www.w3.org/2001/XMLSchema#string

Nora Bandi

http://www.w3.org/2001/XMLSchema#string

P2860

miR-15 and miR-16 induce apoptosis by targeting BCL2

Widespread microRNA repression by Myc contributes to tumorigenesis

miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes.

The impact of microRNAs on protein output

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation

Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression

Proliferation, cell cycle and apoptosis in cancer

The miR-34 family in cancer and apoptosis

Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells

miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer

P2888

1476-4598-10-55

P304

55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-4598-10-55

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51129586

http://www.w3.org/2001/XMLSchema#string

P6179

1035922843

http://www.w3.org/2001/XMLSchema#string

P698

21575235

http://www.w3.org/2001/XMLSchema#string

P932

3120797

http://www.w3.org/2001/XMLSchema#string